Diagnostic performance and interobserver agreement of O-RADS US v2022 and its combination with serum biomarkers in surgically treated epithelial ovarian-adnexal masses

Ying Li, Xiaoqin He, Liping Chen, Liping Zhong, Xiaohong Zhong, Yuning Lin

Open source

DOI
10.3389/fmed.2026.1930481
Published
9
Container
Frontiers in Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1930481,
  title = {Diagnostic performance and interobserver agreement of O-RADS US v2022 and its combination with serum biomarkers in surgically treated epithelial ovarian-adnexal masses},
  author = {Ying Li and Xiaoqin He and Liping Chen and Liping Zhong and Xiaohong Zhong and Yuning Lin},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1930481},
  url = {https://doi.org/10.3389/fmed.2026.1930481}
}

RIS

TY  - JOUR
TI  - Diagnostic performance and interobserver agreement of O-RADS US v2022 and its combination with serum biomarkers in surgically treated epithelial ovarian-adnexal masses
AU  - Ying Li
AU  - Xiaoqin He
AU  - Liping Chen
AU  - Liping Zhong
AU  - Xiaohong Zhong
AU  - Yuning Lin
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1930481
UR  - https://doi.org/10.3389/fmed.2026.1930481
ER  - 

APA

Li, Y., He, X., Chen, L., Zhong, L., Zhong, X., & Lin, Y. (2026). Diagnostic performance and interobserver agreement of O-RADS US v2022 and its combination with serum biomarkers in surgically treated epithelial ovarian-adnexal masses. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1930481

Source records